Results of the First Phase I PIPAC Trial in the United States: Braving the Storm

Ann Surg Oncol. 2023 Dec;30(13):7923-7925. doi: 10.1245/s10434-023-14353-y. Epub 2023 Sep 28.

Authors

Beatrice J Sun¹, Byrne Lee²

Affiliations

¹ Section of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
² Section of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. byrnelee@stanford.edu.

PMID: 37770724
DOI: 10.1245/s10434-023-14353-y

No abstract available

Publication types

Editorial

MeSH terms

Aerosols
Cisplatin*
Doxorubicin*
Humans
United States

Substances

Aerosols
Cisplatin
Doxorubicin